ShareValue scores for ALKEY.PA: Valuation 42, Quality 52, Growth 30, Health 46.

ALKEY.PA
Euronext Paris

Keyrus SA

€8.14(+2.52%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

4% to 15%
Valuation
42
Fair Value
Price vs Value
Quality
52
Moderate
Business Strength
Growth
30
Weak
Revenue & Earnings
Health
46
Moderate
Financial Stability
Momentum
47
Neutral
Price Trend

Company Details

About

Keyrus S.A., a consultancy company, engages in the development of data and digital solutions for performance management worldwide. It provides data advisory and consulting services, such as data and AI strategies, roadmap and scoping study, architecture and technology consulting, decision intelligence, and data governance; and data and analytic solutions, including data platforms, visualization and storytelling, quality and governance, and mesh and fabric, as well as cloud data management. The company also offers artificial intelligence (AI) literacy and understanding, strategy and prioritization, testing and development, production and scale-up, modeling and evaluation, and governance services; enterprise performance management services, such as performance analytics, consolidation and regulatory reporting, and profitability and cost management as well as planning, budgeting, and forecasting; and digital and multi-experience services, including digital strategy consulting, customer data platform, marketing automation, and omnichannel commerce. It provides its offerings under the Keyrus Life Science, Absys Cyborg, Younicorns, Vision.bi, and CMG Consulting Group brands. The company was founded in 1996 and is headquartered in Levallois-Perret, France.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026